approval
saveEMTRICITABINE, RILPIVIRINE, AND TENOFOVIR ALAFENAMIDE (EMTRICITABINE) — FDA approval
community read0 votes
Sponsor: APOTEX. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 1
same company · ±60 days · 6
- approvalPREGABALIN: PREGABALIN — FDA approvalFeb 2, 2026
- approvalDificid: FIDAXOMICIN — FDA approvalFeb 2, 2026
- approvalpaliperidone ER: PALIPERIDONE — FDA approvalJan 26, 2026
- approvalIBANDRONATE SODIUM: IBANDRONATE SODIUM — FDA approvalFeb 3, 2026
- approvalIBANDRONATE SODIUM: IBANDRONATE SODIUM — FDA approvalFeb 3, 2026
- approvalIBANDRONATE SODIUM: IBANDRONATE SODIUM — FDA approvalFeb 3, 2026
🐶 often sniffed alongside
top 6- drugEMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE12 co-mentions · 3 sources
- drugEMTRICITABINE, RILPIVIRINE, AND TENOFOVIR ALAFENAMIDE12 co-mentions · 3 sources
- tagApproval12 co-mentions · 3 sources
- tagSmall Molecule6 co-mentions · 3 sources
- drugtenofovir alafenamide4 co-mentions · 2 sources
- drugTENOFOVIR DISOPROXIL FUMARATE2 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that